Enantioseparation of Cinacalcet, and its Two Related Compounds by HPLC with Self-Made Chiral Stationary Phases and Chiral Mobile Phase Additives

Author(s): Canyu Yang, Ji Li, Yanyun Yao, Chen Qing*, Baochun Shen*.

Journal Name: Current Pharmaceutical Analysis

Volume 15 , Issue 2 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Background: Cinacalcet is one of the second-generation calcimimetics which consists of a chiral center. The pharmacological effect of R-cinacalcet is 1000 times greater than that of the Scinacalcet. As mentioned in many literatures, 1-(1-naphthyl)ethylamine is used as the starting material for the synthesis of cinacalcet. The absolute structure of cinacalcet is influenced by the starting materials.

Methods: We present the chiral separation of cinacalcet and its starting material, 1-(1-naphthyl) ethylamine along with one of its intermediates, N-(1-(naphthalen-1-yl) ethyl)-3- (3-(trifluoromethyl) phenyl) propanamide by high-performance liquid chromatography with chiral stationary phase and chiral mobile phase additives.

Results: On vancomycin and cellulose tri 3,5-dimethylphenylcarbamate) chiral stationary phase, cinacalcet and 1-(1-naphthyl)ethylamine achieved enantioseparation under normal phase with addition of triethylamine additives, respectively. Meanwhile, 1-(1-naphthyl)ethylamine and N-(1-(naphthalen-1- yl)ethyl)-3-(3-(trifluoromethyl) phenyl) propanamide achieved enantioseparation on 1-napthalene vancomycin chiral stationary phase using D-tartaric acid, diethyl L-tartrate and diethyl D-tartrate as chiral mobile phase additives.

Conclusion: The chiral recognition in our experiment was based on the hydrogen-bonding, dipoledipole and π-π interactions among the solutes, chiral stationary phases and chiral mobile phase additives. In addition, the space adaptability of chiral stationary phases also affected the separation efficacy.

Keywords: Enantioseparation, cinacalcet, 1-(1-naphthyl) ethylamine, N-(1-(naphthalen-1-yl) ethyl)-3- (3-(trifluoromethyl) phenyl) propanamide, chiral mobile phase additive, chiral stationary phase.

Barniol-Xicota, M.; Leiva, R.; Escolano, C.; Vázquez, S. Syntheses of cinacalcet: An enantiopure active pharmaceutical ingredient (API). Synthesis, 2016, 48, 783-803.
Torres, P.U. Cinacalcet HCl: A novel treatment for tertiary hyperparathyroidism caused by chronic kidney disease. J. Ren. Nutr., 2006, 16, 253-258.
Nemeth, E.F.; Heaton, W.H.; Miller, M.; Fox, J.; Balandrin, M.F.; Van Wagenen, B.C.; Colloton, M.; Karbon, W.; Scherrer, J.; Shatzen, E.; Rishton, G.; Scully, S.; Qi, M.; Harris, R.; Lacey, D.; Martin, D. Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl. J. Pharmacol. Exp. Ther., 2004, 308, 627-635.
Brauner-Osborne, H.; Wellendorph, P.; Jensen, A. Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors. Curr. Drug Targets, 2007, 8, 169-185.
Siddiqui, M.R.; AlOthman, Z.A.; Rahman, N. Analytical techniques in pharmaceutical analysis: A review. Arab. J. Chem., 2017, 10, S1409-S1421.
AlOthman, Z.A.; Rahman, N.; Siddiqui, M.R. Review on pharmaceutical impurities, stability studies and degradation products. Rev. Adv. Sci. Eng., 2013, 2, 155-166.
Rahman, N.; Azmi, S.N.H.; Wu, H.F. The importance of impurity analysis in pharmaceutical products: an integrated approach. Accredit. Qual. Assur., 2006, 11, 69-74.
Shinde, G.B.; Niphade, N.C.; Deshmukh, S.P.; Toche, R.B.; Mathad, V.T. Industrial application of the forster reaction: novel one-pot synthesis of cinacalce hydrochloride, a calcimimetic agent. Org. Process Res. Dev., 2014, 15, 455-461.
Ravinder, V.; Ashok, S.; Satish, V.M.; Raghunath, B.C.V.; Shanker, K.; Balaswamy, G. A validated chiral LC method for the enantiomeric separation of cinacalcet hydrochloride. Chromatographia, 2009, 70, 229-232.
Bhushan, R.; Dubey, R. Indirect reversed-phase high-performance liquid chromatographic and direct thin-layer chromatographic enantioresolution of (R, S) cinacalcet. Biomed. Chromatogr., 2011, 25, 674-679.
Dousa, M.; Brichác, J. Chiral chromatography studies of chemical behavior of cinacalcet on polysaccharide chiral reversed-phase HPLC stationary phase. J. AOAC Int., 2012, 95, 1639-1643.
Ramisetti, N.R.; Bompelli, S. LC-MS/MS determination of cinacalcet enantiomers in rat plasma on Chirobiotic V column in polar ionic mode: Application to a pharmacokinetic study. Biomed. Chromatogr., 2014, 28, 1846-1853.
Mei, X.M.; Chen, W. Determination of enantiomer of R-1-(1-naphthyl) ethylamine by HPLC. West Chin J. Pharm. Sci., 2014, 29, 75-76.
Mei, X.M.; Chen, W.; Bai, Z.W. Enantioseparation characteristics of the chiral stationary phases based on natural and regenerated chitins. J. Sep. Sci., 2017, 40, 1710-1717.
Younes, A.A.; Ates, H.; Mangelings, D.; Vander, H.Y. A separation, strategy combining three HPLC modes and polysaccharide-based chiral, stationary phases. J. Pharmaceut. Biomed., 2013, 75, 74-85.
Armstrong, D.W.; Tang, Y.B.; Chen, S.S.; Zhou, Y.W.; Bagwill, C.; Chen, J.R. Macrocyclic antibiotics as a new class of chiral selectors for liquid chromatography. Anal. Chem., 1994, 66, 1473-1484.
Armstrong, D.W.; Zhang, B. Chiral stationary phases for HPLC. Anal. Chem., 2001, 73, 557A-561A.
Felix, G.; Berthod, A. Commercial chiral stationary phases for the separation of clinical racemic drugs. Separ. Purif. Rev., 2007, 36, 285-481.
Berthod, A.; Xiao, T.L.; Bagwill, C.; Armstrong, D.W. Separation of chiral sulfoxides by liquid chromatography using macrocyclic glycopeptides chiral stationary phases. J. Chromatogr. A, 2002, 955, 53-59.
Berthod, A. Chiral recognition mechanisms with macrocyclic glycopeptide selectors. Chirality, 2009, 21, 167-175.
Zhang, Z.; Yang, G.; Liang, G.; Liu, H.; Chen, Y. Chiral separation of Tamsulosin isomers by HPLC using cellulose Tris (3, 5-dimethhylphenylcarbamate) as a chiral stationary phase. J. Pharmaceut. Biomed., 2004, 34, 689-693.
Ceccato, A.; Hubert, P.; Tullio, P.D.; Liégeois, J.F.; Felikidis, A.; Géczy, J. Enantiomeric separation of pirlindole by liquid chromatography using different types of chiral stationary phases. J. Pharmaceut. Biomed., 1998, 18, 605-614.
Zhang, T.; Nguyen, D.; Franco, P.; Isobe, Y.; Michishita, T.; Murakami, T. Cellulose, tris (3, 5-dichlorophenylcarbamate) immobilised on silica: A novel chiral stationary phase for resolution of enantiomers. J. Pharmaceut. Biomed., 2008, 46, 882-891.
Okamoto, Y.; Kaida, Y. Resolution by high-performance liquid chromatography using polysaccharide carbamates and benzoates as chiral stationary phases. J. Chromatogr. A, 1994, 666, 403-419.
He, H.M.; Xu, X.Z.; Zhang, D.T.; Chen, J.J. Enantioseparation of alkyl tropate by high performance liquid chromatography using (2R, 3R)-di-n-propyl tartrate. Anal. Chim. Acta, 2005, 536, 15-20.
Pan, C.X.; Shen, B.C.; Xu, B.J.; Chen, J.J.; Xu, X.Z. Comparative enantioseparation of seven triazole fungicides on (S, S)-Whelk O1 and four different cellulose derivative columns. J. Sep. Sci., 2006, 29, 2004-2011.
Shao, B.H.; Xu, X.Z.; Lv, J.D.; Cai, X.J.; Fu, X.Y. Enantioseparations of three kinds of methoxyflavanones on cellulose derivative chiral columns and chiral recognition mechanism. Acta Chimi. Sin., 2003, 61, 440-443.
Shen, B.C.; Yuan, J.Y.; Wang, H.C.; Xu, B.J.; Xu, X.Z. Enantioseparation of three aryloxyphenoxypropionic acids herbicides on CDMPC and vancomvcin CSP column. J. Instrum. Anal., 2008, 27, 1379-1382.
Shen, B.C. The preparation and enantioseparation of macrocyclic antibiotics and their derivatives chiral stationary phase. PhD Thesis, Zhejiang University, Zhejiang, China,, 2007.
Yu, X.Y.; Gu, X.J.; Xie, Y.; Qu, S.L.; Shen, B.C. Separation of enantiomers of 6 alkamine drugs on 1-napthalene vancomycin chiral stationary phase. PTCA (Part B: Chem. Anal.),, 2012, 48, 884-892.
Shen, B.C.; Xu, X.Z.; Zhang, X.J.; Chen, J.J. Enantioseparation and chiral recognition mechanism of two novel organic phosphonate derivatives on chiral stationary phases. Anal. Lett., 2005, 38, 1317-1330.
Yu, X.Y.; Gu, X.J.; Xie, Y.; Qu, S.L.; Shen, B.C. Separation of enantiomers of 6 alkamine drugs on 1-napthalene vancomycin chiral stationary phase. PTCA (Part B: Chem. Anal.),, 2012, 48, 884-892.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2019
Page: [200 - 209]
Pages: 10
DOI: 10.2174/1573412914666180518105046

Article Metrics

PDF: 25